Latest filing published 22 Nov 2023 for GYRE THERAPEUTICS, INC.. Read the official filing
No signal scores available.
All filings by GNI Group Ltd. on record concern Gyre Therapeutics, Inc. In total, 2 filings cover trades dated from 31 August 2023 to 30 October 2023.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 22 November 2023, the filings show a transaction in Gyre Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations